Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Krzentowski

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Revue Medicale De Bruxelles|April 1, 1988
[Oral antidiabetic agents, yes but...]G Krzentowski
Revue Medicale De Liege|July 23, 2005
[The role of diabetes associations]G Krzentowski
Revue Medicale De Bruxelles|October 26, 2005
[The new insulins]G Krzentowski
Annales D'Endocrinologie|December 1, 1981
[Familial partial resistance to thyroid hormones. A report on one case (author's transl)]G Krzentowski, J L Vandalem
Acta Clinica Belgica|January 1, 1979
[Glucose metabolism during muscular exercise in McArdle's disease]G Krzentowski, N Pallikarakis, F Pirnay
La Nouvelle Presse Medicale|September 25, 1982
[Value of the artificial pancreas in the diagnosis of organic hypoglycemia]A Scheen, G Krzentowski, A Luyckx, et al.
Annales D'Endocrinologie|November 20, 2004
[Another look at the implications of the DCCT study]G Krzentowski, L Zhang, A Albert, et al.
Diabetes Care|June 26, 2001
Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic controlL Zhang, G Krzentowski, A Albert, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 26, 2003
Factors predictive of nephropathy in DCCT Type 1 diabetic patients with good or poor metabolic controlL Zhang, G Krzentowski, A Albert, et al.
Diabetologia|May 1, 1983
A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate controlG Krzentowski, A Scheen, M Castillo, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Revue Medicale De Bruxelles|April 1, 1988
[Oral antidiabetic agents, yes but...]G Krzentowski
Revue Medicale De Liege|July 23, 2005
[The role of diabetes associations]G Krzentowski
Revue Medicale De Bruxelles|October 26, 2005
[The new insulins]G Krzentowski
Annales D'Endocrinologie|December 1, 1981
[Familial partial resistance to thyroid hormones. A report on one case (author's transl)]G Krzentowski, J L Vandalem
Acta Clinica Belgica|January 1, 1979
[Glucose metabolism during muscular exercise in McArdle's disease]G Krzentowski, N Pallikarakis, F Pirnay
La Nouvelle Presse Medicale|September 25, 1982
[Value of the artificial pancreas in the diagnosis of organic hypoglycemia]A Scheen, G Krzentowski, A Luyckx, et al.
Annales D'Endocrinologie|November 20, 2004
[Another look at the implications of the DCCT study]G Krzentowski, L Zhang, A Albert, et al.
Diabetes Care|June 26, 2001
Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic controlL Zhang, G Krzentowski, A Albert, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 26, 2003
Factors predictive of nephropathy in DCCT Type 1 diabetic patients with good or poor metabolic controlL Zhang, G Krzentowski, A Albert, et al.
Diabetologia|May 1, 1983
A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate controlG Krzentowski, A Scheen, M Castillo, et al.
Pageof 4